Introduction cells, as the DHFR coding region consists of only 564 bp, One use of gene transfer for cancer treatment is to transis easy to express and several drug resistant mutants are fer drug resistance genes into bone marrow cells to proavailable for study. [11] [12] [13] [14] [15] [16] In addition, the selection agent, tect bone marrow from toxicity of high-dose chemo-MTX, has been used extensively for treatment of nontherapy. 1 For this purpose, mutated dihydrofolate malignant diseases as well as malignant neoplasms, and reductase (DHFR) [2] [3] [4] genes to produce methotrexate the spectrum of side-effects is well known. 17 In this study, (MTX) resistance, and the multidrug resistance gene we show that resistance to MTX may be augmented by (Mdr1) [5] [6] [7] have received the most attention, although increasing thymidine salvage by utilizing a retroviral vecother drug resistance genes such as aldehyde dehydrotor containing both a mutated DHFR and the HSVtk genase class I are also being studied. 8 As the level of cDNA, thus bypassing the block on synthesis of thymidresistance obtained from transfer of one or a few copies ylate. In addition, this construct will also allow eradiof these cDNAs by retroviral vectors into human or large cation of inadvertently transduced tumor cells, a possible animal marrow cells is modest, efforts have been made drawback of transfer of drug resistance genes into bone to potentiate the resistance conferred by this method. marrow cells contaminated by tumor cells. The HSVtk Hematopoietic progenitor cells transduced in vitro can gene sensitizes cells to a prodrug, ganciclovir (GCV), and repopulate in bone marrow even without myeloablation, has been used extensively in gene therapy experiments although a large number of hematopoietic cells may be and clinical applications as a suicide gene. Retrovirus, viral producer cell lines S and Bertino JR, unpublished observations). An altered
The retrovirus vector, DC/SV6S31tk used in this study, is shown in Figure 1 . DC/SV6S31 has the same structure, except that it contains the neomycin resistance gene Cytotoxicity of ganciclovir to virus-transduced cells DC/SV6S31tk and DC/SV6S31 infected cells were exposed to ganciclovir (GCV) in 96-well plates for 5 days as described (see Materials and methods). As shown in Figure 4 , the ID 50 of ganciclovir to HSVtk-containing cells was 500-fold less than non-tk containing cells, indicating that cells selected with MTX also expressed HSVtk.
Expression of mRNA for mDHFR and HSVtk
In order to measure the expression of the transduced cDNAs, Northern analysis was performed (see Materials 
(-+ -), 3T3 cells infected with the DC/SV6S31 vector (-ć -), and the

Expression levels of both DHFR and HSVtk increased
DC/SV6S31tk vector (-̅ -). Cells were transduced and XTT assay was performed as described in Materials and methods.
with exposure of cells to MTX ( Figure 6 ). It is of note that HSVtk expression levels were higher after 1 week in the infected with DC/SV6S31tk than the cells infected with DC/SV6S31 or mock-infected cells (Table 1) . MTX selection, whereas DHFR expression was higher after a 3-week period of selection. These experiments were repeated three times with similar results.
Discussion
Co-expression of HSVtk with Ser31-mutated DHFR augAnalysis of gene amplification in transduced cells Southern blot analysis was performed to compare the ments resistance to MTX. Although the increase in the ID 50 was only 10-fold compared to DC/SV6S31, approxiaverage copy numbers of the proviral sequences in the transduced cell lines. After selection with 1 m of MTX, mately 20% of cells infected with the DC/SV6S31tk vector survived a very high concentration of MTX. The mechdespite increased resistance to MTX and increased expression of DHFR and HSVtk by Northern blot, cells anism of this high level of resistance in a subpopulation of cells is probably due to the rescue of MTX toxicity by did not contain increased copy numbers of DHFR or HSVtk (Figure 7) . increased salvage of thymidine as a result of increased levels of HSVtk in these cells ( Figure 8 ). As expected, after dialyzing serum to remove thymidine, the augmented Transduction of mouse bone marrow in vitro Mouse bone marrow cells were infected with the resistance was lost, as shown in Figure 3 . HSVtk is commonly used as a dominant selectable marker using HAT DC/SV6S31 and DC/SV6S31tk vectors, then cultured 12 days in the presence of MTX at concentrations of 1 and (hypoxanthine-aminopterin-thymidine) medium, 19 which contains aminopterin, an analog of MTX.
12 Thus the 5 × 10 −8 m. More CFU-C colonies were seen in cells also augment the resistance to MTX conferred by the S31 mutated DHFR. 20 Thus, co-expression of metabolically related genes may potentiate the resistance conferred by a drug resistance gene. The present studies show an advantage of the MTX-DHFR selection system as DHFR is a key enzyme in both thymidilate and purine biosynthesis. Thus, resistance to MTX may be increased by coexpression of genes involved in these pathways (Figure transduced with mDHFR alone.
Another important aspect of the construct which contains HSVtk is that this vector also confers sensitivity to expression of HSVtk itself may cause partial resistance to MTX when exogenous thymidine is available. Surpris-GCV to the infected cells. As bone marrow/peripheral stem cells may be contaminated with tumor cells even ingly, the increased expression noted after MTX exposure for 3 weeks was not secondary to increased cDNA copy after CD34 selection, and inadvertent transduction of tumor cells may result in production of drug-resistant numbers, as DHFR mRNA increased with no increase in gene copy number. This increase of mRNA may be due tumor cells, a suicide gene in the same retroviral construct may provide a safeguard against this possibility. to selection of clones which have higher expression of the mDHFR and the HSVtk genes. More investigation is Alternatively, constructs containing both these genes may be used to infect tumor cells followed by treatment warranted to clarify this mechanism.
We previously reported that partial rescue of the with MTX to amplify both DHFR and HSVtk followed by treatment with GCV to preferentially eradicate these purine biosynthesis pathway by co-expression of xanthine-guanine-phosphoribosyl transferase (XGPRT) can cells. The experiments were done in triplicate. Results are shown with colony numbers without MTX as 100.
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HSVtk-containing vectors are also being used for adop-E86 cells and GP-AM12 cells. After a 14-day selection with 750 g/ml of G418, colonies with high titers were tive immunotherapy. 21 In certain protocols, T cells transduced with a vector containing HSVtk and a nerve selected, and the supernatants from the ecotropic producer cell lines were used to infect amphotropic producer growth factor receptor were selected in vitro after transduction. Transduced T cells can be eliminated with GCV cell lines two to three times. Titers of these producer cell lines were measured with 3T3 cells as target cells, and in vivo, but can not be positively selected in vivo. On the other hand, DC/SV6S31tk is a vector which allows both the highest titer colonies were used for further experiments. The titers of these colonies were approximately positive selection (with MTX) and negative selection (with GCV) in vivo using clinically approved drugs.
1 × 10 5 c.f.u./ml. Producer cells were replated in 60 mm plates, grown up to 70% confluency, then medium was changed to either DME-HG with 10% FBS for 3T3 cell
Materials and methods
infection or IMDM-10% FBS medium for bone marrow cell infections. The next day the supernatant was colCells lected, centrifuged at 2000 g for 20 min to remove cell NIH3T3 cells are cultured in Dulbecco's modified Eagledebris, and stored frozen at −80°C until use. high glucose (with 4.5 g/l of glucose) (DME-HG)
The titers were measured with NIH3T3 cells as target medium with 10% fetal bovine serum (FBS). The viral cells. Briefly, 1 × 10 5 cells were plated in 60 mm plates packaging cell lines, GP-E86 and GP-envAM12 line, an and appropriately diluted virus supernatant was added ecotropic and an amphotropic line, respectively, have to the plates, in the presence of 8 g/ml of polybrene. been described previously.
22,23
After 3 h of exposure to diluted supernatant, normal medium was added. The next day, medium was changed Retrovirus constructs to the one containing 100 nm of MTX. This concentration The pSV4S31 mammalian expression vector, which conof MTX is known to kill all noninfected cells but have a tains the SV40 early promoter and a Serine 31 mutated minimal effect on infected cells. The colonies were coun-DHFR cDNA, 12 was used as a template to obtain a full ted 2 weeks later, and the titer was calculated and is length Ser31 mutated DHFR cDNA by PCR. Primers used expressed as c.f.u./ml. for this reaction were: GTHindIII-1 TTCAGTATAAGHelper virus production was monitored with vector CTTATCCGCGTGCTGTCATGGTTGGTTCGCT and rescue assays. 28 In brief, 3T3 cells transfected with retroGT564BglII ACAGAACAAGATCTCCTTCATATTAATvirus vector containing the Neo r gene were infected with CATTCTTCTCATA. viral supernatant. After a week of culture, supernatant PCR conditions were 94°C for 30 s, 55°C for 30 s, and from these cells was harvested and wild-type 3T3 cells 72°C for 30 s, for 35 cycles. The PCR product obtained exposed to these supernatants. The cells were then subwas digested with HindIII and BglII, and subcloned into jected to G418 selection. No helper virus was detected in a pSV2 vector which was previously digested with viral supernatants. HindIII/BglII, to generate the pSV6S31 mammalian expression vector. The pSV6S31 construct contains only Cytotoxicity of MTX and GCV to the cells infected with the DHFR coding region, and was found to be at least retroviral vectors 10-fold more efficient than pSV4S31, which contains 3T3 cells were exposed to the supernatant containing approximately 90 bp of the 3′-untranslated region of retroviral vectors for 3 h, in the presence of 8 g/ml of DHFR cDNA. PvuII/BglII digestion releases the fragment polybrene. Multiplicity of infection (MOI) was more than of DNA which contains the SV40 early promoter and S31 10 for most of these experiments. After 3 h, fresh medium DHFR cDNA. This fragment was blunt-ended with was added, then at 24 h medium was changed to DMEKlenow enzyme, and inserted into the SnaBI site of the HG containing 20 nm of trimetrexate (TMTX) for 3-day N2A Moloney murine leukemia virus vector 24 to produce selection. This concentration of TMTX is 100% lethal to DC/SV6S31. This vector contains the SV40 promoter and noninfected 3T3 cells, but is not inhibitory to infected the S31 DHFR cDNA cloned into the 3′-LTR. Thus upon cells. Also, this 3-day selection does not change the ID 50 infection of target cells, this expression unit is duplicated of infected cells (data not shown). After the 3-day selecin the 5′-LTR, to form a double copy structure. 25, 26 This tion, cells were plated in 96-well plates, and cytotoxicity vector was digested with BclI at 65°C overnight, bluntmeasured by a colorimetric assay using XTT, sodium 3′-ended with Klenow enzyme, and then cut with XhoI. A (1-((phenylamino)-carbonyl)-3,4-tetrazolium)-bis(4-methHSVtk-containing vector, TEL-1 (kind gift of Dr Michel oxy-6-nitro)benzene-sulfonic acid hydrate, as described Sadelain, MSKCC) 27 was digested with XbaI/XhoI, and previously. 29 Cells were plated at a concentration of 400 the released fragment cloned into pBluescriptSKII cells per well, and 24 h later, medium was changed to a (Stratagene, La Jolla, CA, USA) and digested with the drug-containing one. After 5 days of exposure to drugs, same combination of enzymes. The resulting vector, 50 l of XTT at a concentration of 1 mg/ml, was added pBHSVtk was digested with ScaI, blunt-ended with T4 together with phenazine methosulfate (PMS). After a 3-DNA polymerase, then digested with XhoI and cloned h incubation at 37°C, the OD at 450 nm was measured into the blunt-end/XhoI fragment of DC/SV6S31, using a 96-well plate reader. The absorbance was plotted resulting in DC/SV6S31tk (Figure 1 with the Betascope were performed as described above.
